Shares of Johnson & Johnson (NYS:JNJ) slipped 2.39% to $155.93 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index (S&P:SPX) falling 1.90% to 4,567.00 and Dow Jones Industrial Average (DOW:DJIA) falling 1.86% to 34,483.72. Johnson & Johnson closed $23.99 below its 52-week high ($179.92), which the company achieved on August 20th.
The stock underperformed when compared to some of its competitors Tuesday, as Roche Holding AG Part. Cert. (OTC:RHHVF) fell 1.28% to $385.00, Merck & Co. Inc. (NYS:MRK) rose 0.03% to $74.91, and Pfizer Inc. (NYS:PFE) rose 2.54% to $53.73. Trading volume (14.4 M) eclipsed its 50-day average volume of 6.7 M.